Toobit Lists DOODUSDT Perpetual Contract – Toobit

Dear Toobiters，

Toobit has listed DOOD Perpetual Contract on 2025-05-09 (UTC), with up to 50x leverage.

Trade Now: DOODUSDT

For more details on DOOD Perpetual Contract, please refer to the table below:

USDⓈ-M Perpetual Contract	DOODUSDT
Underlying Asset	DOOD
Settlement Asset	USDT
Tick Size	0.0000001
Capped Funding Rate	2.0000% / -2.0000%
Funding Fee Settlement Frequency	every 4 hours
Maximum Leverage	50x

Please Note:

The maximum funding rate of the DOOD Perpetual Contract at the time of launch is 2.0000% / -2.0000%

To protect user rights and interests and mitigate risks under extreme market conditions, Toobit may periodically adjust parameters for perpetual contracts based on market risk assessments. These adjustments may include but are not limited to: minimum price movement unit, maximum leverage, initial margin, maintenance margin, and funding rates. No separate announcements will be issued for such parameter updates. For the latest details, please refer to the specifications on the trading interface.

Thank you for choosing Toobit for your trading needs. We remain committed to providing the best platform for cryptocurrency enthusiasts!

Toobit Team

2025-05-09

Download the Toobit App Now

Find us:

X: https://x.com/Toobit_official

Telegram: https://t.me/Toobit_EN

Discord: https://discord.com/invite/vvxTuGTz

YouTube: https://www.youtube.com/@Toobit_official

Reddit: https://www.reddit.com/r/toobit/

Facebook: https://www.facebook.com/toobitofficial

Medium: https://medium.com/toobit-exchange

Toobit reserves the right to modify or cancel this announcement at any time and for any reason without prior notice.

Risk Warning: The prices of digital assets may fluctuate significantly. The value of your investment may increase or decrease, and you may even lose the entire amount invested. You are solely responsible for your investment decisions, and Toobit is not liable for any losses that may occur due to the use of margin trading. This information should not be considered financial or investment advice. Please refer to our Terms of Use and Risk Disclosure for more details.

Related articles